FY2028 EPS Estimates for Organigram Cut by Atb Cap Markets

Key Points

• Analysts at Atb Cap Markets have lowered their FY2028 earnings estimates for Organigram Holdings, now projecting earnings of $0.14 per share, down from a previous estimate of $0.15.
• Organigram's current share price is C$2.09, with a market capitalization of C$258.20 million and a negative price-to-earnings ratio of -4.42.
• The company focuses on producing indoor-grown cannabis for both medical and recreational consumers and aims to develop global business partnerships.

Organigram Holdings Inc. (TSE:OGI - Free Report) - Equities researchers at Atb Cap Markets dropped their FY2028 EPS estimates for Organigram in a note issued to investors on Wednesday, August 13th. Atb Cap Markets analyst F. Gomes now forecasts that the company will post earnings per share of $0.14 for the year, down from their previous estimate of $0.15. The consensus estimate for Organigram's current full-year earnings is $0.16 per share.

Organigram Stock Performance

Shares of TSE:OGI traded down C$0.02 during trading on Friday, reaching C$2.07. The stock had a trading volume of 41,924 shares, compared to its average volume of 173,167. Organigram has a 52 week low of C$1.22 and a 52 week high of C$2.79. The firm has a market capitalization of C$255.73 million, a price-to-earnings ratio of -4.38, a P/E/G ratio of 0.42 and a beta of 1.13. The company has a quick ratio of 2.62, a current ratio of 3.36 and a debt-to-equity ratio of 3.07. The stock has a fifty day simple moving average of C$1.96 and a two-hundred day simple moving average of C$1.77.

About Organigram

Organigram Inc is a Canadian licensed producer of cannabis products. Organigram focuses on producing exceptional, indoor-grown cannabis for patients and adult recreational consumers, as well as developing global business partnerships.